![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tod M.M.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.40, Iss.11, 2001-01, pp. : 803-814
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aminoglycoside Dosage Regimens After Therapeutic Drug Monitoring
Clinical Pharmacokinetics, Vol. 41, Iss. 10, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?
By Perucca E.
Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetics: The Therapeutic Drug Monitoring of the Future?
By Ensom M.H.H.
Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is it Time for Reporting Guidelines for Calibration Methods?
PharmacoEconomics, Vol. 27, Iss. 7, 2009-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Health Utility Elicitation: Is There Still a Role for Direct Methods?
PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. :